Parvovirus B19 Immunoassay

Company
University of Leiden (Sub-licensed: Biotrin International)
Use
Detection of B19 virus IgM antibodies in human serum and plasma
Features
First diagnostic test for parvovirus B19 infection approved by the FDA
NIH Contribution
Recombinant capsid proteins and antibodies against them.
Approval Type
FDA
HHS Institute/Agency
NHLBI
Inventor(s)
N. Young
Year
1999
Tech Cat
Diagnostic

Request More Info

L-221-2002